Purification of flavan-3-ol biosynthesis for co-localization onto nanocarriers and a multi-enzyme assay by Davenport, Emily Kaitlin
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2011
Purification of flavan-3-ol biosynthesis for co-
localization onto nanocarriers and a multi-enzyme
assay
Emily Kaitlin Davenport
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Biological Engineering Commons, and the Chemical Engineering Commons
This Thesis is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital
Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital
Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Davenport, Emily Kaitlin, "Purification of flavan-3-ol biosynthesis for co-localization onto nanocarriers and a multi-enzyme assay"
(2011). Graduate Theses and Dissertations. 10173.
https://lib.dr.iastate.edu/etd/10173
Purification of flavan-3-ol biosynthesis for co-localization onto 
nanocarriers and a multi-enzyme assay 
 
by 
 
Emily Kaitlin Davenport 
 
 
 
A thesis submitted to the graduate faculty 
in partial fulfillment of the requirements for the degree of 
MASTER OF SCIENCE 
 
Major: Chemical Engineering 
Program of Study Committee: 
Surya Mallapragada, Co-Major Professor 
Reuben Peters, Co-Major Professor 
Balaji Narasimhan 
 
 
 
 
 Iowa State University of Science and Technology 
Ames, Iowa  
2011  
Copyright © Emily Kaitlin Davenport, 2011. All rights reserved.   
ii 
 
Table of Contents 
 
List of Figures ................................................................................................................... iv 
List of Tables .................................................................................................................... vi 
Abstract ............................................................................................................................ vii 
 
Chapter 1: General Introduction .....................................................................................1 
Overview ........................................................................................................................1 
Flavonoid Pathway.........................................................................................................2 
Flavonoids ......................................................................................................................5 
Structure .................................................................................................................. 5 
Leucoanthocyanidins .............................................................................................. 6 
Anthocyanidins ....................................................................................................... 6 
Flavan-3-ols ............................................................................................................ 7 
Proanthocyanidins ................................................................................................... 9 
DFR ....................................................................................................................... 10 
ANS....................................................................................................................... 11 
ANR ...................................................................................................................... 13 
Enzyme Attachment .....................................................................................................14 
Hypothesis .........................................................................................................................16 
 
Chapter 2: Purification of Arabidopsis DFR, ANS, and ANR for site-specific 
attachment onto a chemically modified nanocarrier ....................................................17 
Abstract ........................................................................................................................17 
Introduction ..................................................................................................................17 
iii 
 
Methods........................................................................................................................21 
Materials ............................................................................................................... 21 
DNA Manipulations .............................................................................................. 21 
Expression ............................................................................................................. 23 
Purification of AtANR .......................................................................................... 24 
Purification of AtDFR........................................................................................... 25 
Purification of AtANS .......................................................................................... 25 
Activity Assays ..................................................................................................... 26 
Thrombin Cleavage ............................................................................................... 28 
Results ..........................................................................................................................28 
Discussion ....................................................................................................................34 
 
Chapter 3: General Conclusions.....................................................................................39 
References .........................................................................................................................40 
Acknowledgements ..........................................................................................................47 
 
  
iv 
 
List of Figures 
Figure 1. Schematic of the flavonoid pathway.  CHS: Chalcone Synthase, CHI: 
Chalcone Isomerase, F3(„)H: Flavonol 3(„)-Hydroxylase, FLS: 
Flavonol Synthase, DFR: Dihydroflavonol 4-Reductase, ANS: 
Anthocyanidin Synthase, UFGT: UDP-glucose: flavonoid 3-O-
glucosyltransferase , ANR: Anthocyanidin Reductase, LAR: 
Leucoanthocyanidin Reductase. Grayed ANS reactions are side 
products uninvolved in final product synthesis. LAR (italicized with 
dashed line) is not present in A. thaliana. ...........................................................3 
Figure 2. General structures for each class of flavonoid .....................................................5 
Figure 3. Both A-type and B-type (-)-epicatechin dimers ...................................................9 
Figure 4. Crystal structure of ANS from A. thaliana, complexed with narigenin 
(Turnbull, Prescott et al. 2001) ..........................................................................11 
Figure 5. Different reactions catalyzed by ANS. Note that substrate 
stereochemistry may vary product ratios...........................................................12 
Figure 6. Flavan-3-ol monomers. Substrates are italicized, enzymes are denoted in 
bold. ...................................................................................................................13 
Figure 7. Late flavonoid pathway in Arabidopsis thaliana. Grayed arrows are 
noted in vitro reactions ......................................................................................18 
Figure 8. PCR product of ANS. Lane 1) 500 bp ladder, lane 2) PCR product to be 
purified from ANS/pDONR, lane 3) positive ANS control from original 
pUC57 vector ....................................................................................................29 
Figure 9. Left - DFR assay extracts after acid hydrolysis to convert leucocyanidin 
to cyanidin (pink). Right – control (clear) .........................................................29 
v 
 
Figure 10. Purification of DFR/pDest15 - (starting from left) lane 1) lysate, lanes 
2-4) resin washes, lane 5) eluate, lane 6) empty, lane 7) standard ladder .........30 
Figure 11. Lysate kinetics for AtDFR as an untagged enzyme (pDest14) and with 
a GST tag (pDest15). Absorbance at 550 nm corresponds to the amount 
of cyanidin resulting from the acid hydrolysis of leucocyanidin 
produced by the enzyme ....................................................................................30 
Figure 12. FPLC chromatogram of purifying AtANR; purified protein peak 
between 3.5-4 mL ..............................................................................................31 
Figure 13. Averaged ANR assay results showing increasing absorbance at 280 
nm, the maximum absorbance wavelength for epicatechin. Data was 
taken from two different purification batches ...................................................32 
Figure 14. TLC with ANR assay extractions. Lane 1) ANR with no substrate, lane 
2) ANR with cyanidin substrate, lane 3) epicatechin standard, lane 4) 
DHQ standard, lane 5) quercetin standard. Rf values for epicatechin in 
assay (0.643) and standard (0.610) ....................................................................32 
Figure 15. TLC of ANS assay extracts. Arrow is pointing to product (quercetin) 
band. Lane 1) ANS assay, lane 2) epicatechin  standard, lane 3) DHQ 
standard, lane 4) quercetin standard. Rf values: for both quercetin 
generated in assay and the quercetin standard at 0.926 .....................................33 
Figure 16. Shows the predicted thrombin cleavage site between the GST tag and 
the ANS enzyme with glycine-serine linker and N-terminal DM3. The 
added 13 amino acids after cleavage are bolded and underlined ......................34 
 
  
vi 
 
List of Tables 
Table 1. List of primers used for cloning PCR, all from 5‟ to 3‟...................................... 22 
Table 2. Specifications for each enzyme and its respective substrate in the collective 
assay buffer ........................................................................................................ 27 
  
vii 
 
Abstract 
Flavonoids are polyphenolic secondary metabolites that serve a variety of purposes, from 
assisting pollination in plants to providing anti-cancerous activity in humans. It is the 
wide range of functions that give these molecules the highly revered status they have 
today. Range in function can be linked with the range in structure, and with over 10,000 
different flavonoids known, they make up one of the largest groups of natural products.  
One common sub-class of flavonoids is the flavan-3-ols, which are known for their health 
benefits and tendency to condense to form proanthocyanidins, or condensed tannins. Both 
of these classes of flavonoids represent the valuable end products of a highly 
investigated, yet still not fully understood, section of flavonoid biosynthesis. 
Furthermore, some of the intermediates are highly unstable and have never been isolated 
in planta. The enzymes that comprise this section are highly interconnected and 
regulated, suggesting that a possible multi-enzyme complex exists. With this evidence, 
we propose to create a synthetic complex using a polymer nanocarrier using 
anthocyanidin synthase and reductase (ANS and ANR, respectively), the final two 
enzymes in flavan-3-ol biosynthesis. Along with the preceding enzyme, dihydroflavonol 
4-reductase (DFR), they have been separately and recombinantly expressed in E. coli. 
Both ANR and ANS are fused to a specific tag for binding to the nanocarrier, ANR – 
6xHis and ANS – (monomeric) streptavidin. Specifying binding sites will allow 
adjustable enzyme concentration and distribution on the nanocarrier. DFR, which has a 
stable substrate, allows for generation of the highly unstable ANS substrate. All three 
enzymes have been designed and purified for co-localization on the nanocarrier and all 
have exhibited activity in an assay designed for the multi-enzyme reaction.
1 
 
Chapter 1: General Introduction 
 
Overview 
One of the most investigated metabolic pathways in plants today is the flavonoid 
metabolic pathway. This pathway produces a variety of flavonoid metabolites, including 
proanthocyanidins and the well-know group of antioxidants: flavan-3-ols. These plant 
natural products have been found to take many forms and can exist as single monomers 
or form compounds as large as 20,000 (Haslam 1998). The amount of interest in this 
pathway began to increase in the 1960‟s when scientists began exploring the biological 
function of these molecules, as little was known about the importance of their role and 
presence. 
Over the years, the actions of flavonoids and their derivatives have been shown to be 
widespread. Generally, flavonoids and flavonoid derivatives have been credited with anti-
viral, anti-cancer, and other preventative health benefits in animals and humans. They are 
also involved in assisting pollination, UV defense, and anti-fungal activity in plants 
(Harborne and Williams 2000; Beecher 2004). 
Flavonoid applications, health benefits, separation, and natural occurrence have been 
reviewed (Gu, Kelm et al. 2003; Aron and Kennedy 2008). Additionally, many 
researchers have investigated and elucidated steps in the upstream flavonoid pathway 
(Burbulis and Winkel-Shirley 1999; Pelletier, Burbulis et al. 1999). Knowledge about the 
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later steps has been slowly accumulating, but full understanding the interactions of these 
enzymes and the final steps of proanthocyanidin synthesis are still lacking.  
Flavonoid Pathway  
The flavonoid pathway stems from the phenylpropanoid pathway. Shown in Figure 1, the 
products of this pathway are flavonols, anthocyanins, flavan-3-ols, and 
proanthocyanidins.  
Accumulation of flavonoids and the enzymes that produce them first occurs in the seed 
coat when it is first exposed to UV light (Pelletier, Murrell et al. 1997) and can suddenly 
increase due to external stress at any time during the life of the plant (Winkel-Shirley 
2002). Mutations resulting in clear to yellowish phenotypes, called transparent testa (tt), 
are missing essential enzymes within this pathway and have produced a number of 
disruptions in the production of pigments in the host plants (Koornneef 1990; Shirley, 
Kubasek et al. 1995). These mutants have given clues to identify the genes and to allow 
the mapping of their loci. Knockout studies, totaling to 24 mutants, have been done to 
analyze the anthocyanidin presence in seedlings in the various stages of plant growth and 
to characterize the pathway (Pelletier, Burbulis et al. 1999; Abrahams, Tanner et al. 2002; 
Abrahams, Lee et al. 2003).  
While there has been a lot of research done on the association and characterization of the 
early steps of the flavonoid pathway, the late steps still lack elucidation. 
Because of the interactive nature of the enzymes in this pathway and the knowledge that 
only a small amount of the enzymes present in the cell are free and soluble (Zalokar 
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1960; Kempner and Miller 1968), speculation began of a flavonoid multi-enzyme 
complex (Burbulis and Winkel-Shirley 1999).  
 
Figure 1. Schematic of the flavonoid pathway.   CHS: Chalcone Synthase, CHI: Chalcone 
Isomerase, F3(„)H: Flavonol 3(„) -Hydroxylase, FLS: Flavonol Synthase, DFR: Dihydroflavonol 
4-Reductase, ANS: Anthocyanidin Synthase, UFGT: UDP-glucose: flavonoid 3-O-
glucosyltransferase , ANR: Anthocyanidin Reductase , LAR: Leucoanthocyanidin Reductase. 
Grayed ANS reactions are side products uninvolved in final product synthesis. LAR (italicized 
with dashed line) is not present in A. thaliana. 
Multi-enzyme complexes, or metabolons, are physical macromolecular assemblies of 
enzymes inside the cell that usually co-exist in the same regulatory pathway.  These 
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enzymes are co-localized often due to limitations in cooperative free-enzyme efficiency 
and product output. Together, in these metabolons, they tend to work with better 
efficiency and with more intra-enzyme cooperation (Winkel 2004). They have been 
mostly investigated in primary metabolism, but have been speculated and explored in 
secondary metabolism as well. Many pieces of evidence for a complex are present in the 
flavonoid pathway.  
Many of the intermediates involved are highly unstable and possibly toxic. Rapid 
transport must occur to accumulate substantial amounts of the final product while 
intermediate levels remain very low (Mathews 1993; Ovadi and Srere 1996). Early 
experiments investigating the idea of a complex show significant evidence that the 
flavonoid pathway may have weak interactions with the ER membrane (Hrazdina and 
Wagner 1985). There is also direct evidence showing that the first two enzymes of the 
flavonoid pathway are co-localized within the cell (Saslowsky and Winkel-Shirley 2001; 
Saslowsky, Warek et al. 2005). There is some debate on the extent of the complex or 
whether it is more likely in a linear or a globular arrangement (Winkel-Shirley 1999).   
Careful regulation of this pathway and its intermediates must also occur. Some products, 
such as quercetin, will inhibit activity in dihydroflavonol 4-reductase (DFR) and 
anthocyanidin reductase (ANR). These are two of the essential enzymes in 
proanthocyanidins and flavan-3-ol synthesis and can be seen in Figure 1. In addition, for 
polymerization of proanthocyanidins (PAs), the extension unit, a leucoanthocyanidin, 
must be more abundant than the initiator unit, a flavan-3-ol (Abrahams, Lee et al. 2003). 
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Many researchers have chosen to use Arabidopsis thaliana as a model organism to study 
flavan-3-ol and PA biosynthesis. Not only does A. thaliana have a fully sequenced 
genome, there are also two unique and simplistic attributes to the Arabidopsis model. 
First, it does not seem to encode an equivalent to leucoanthocyanidin reductase (LAR), 
the enzyme that catalyzes the formation of (+)-catechin. Therefore, the PA makeup and 
stereochemistry is restricted to that of (-)-epicatechin where the average degree of 
polymerization in Arabidopsis is 8 units (Abrahams, Lee et al. 2003). Second, all 
enzymes are encoded by only one gene, with the 
exception of FLS (Winkel-Shirley 2001).  In A. 
thaliana, FLS has been found to have six gene 
copies, but only one of which is responsible for 
activity in the wild type (Pelletier, Murrell et al. 
1997). This is very beneficial to genetic and 
metabolic engineering investigations. 
Flavonoids 
Structure 
Flavonoids are polyphenolic compounds that are 
derived from phenylalanine and acetyl-CoA via 
the phenylpropanoid pathway. They can be 
categorized into 9 sub-classes (see Figure 2) and 
comprise one of the largest banks of natural 
Figure 2. General structures for each 
class of flavonoid 
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products, with over 10,000 naturally occurring (Tahara 2007). The abundance of these 
compounds varies widely depending on their source. 
Most of the flavonoid synthesis occurs in the cytosol and its products are later transported 
to the vacuole, where many of water-soluble compounds are stored (Abrahams, Lee et al. 
2003). The late steps of the flavonoid pathway contain many unstable compounds that are 
converted to compounds with higher function. 
Leucoanthocyanidins 
Leucoanthocyanidins are 3,4-diols that are highly reactive intermediates in the flavonoid 
pathway, shown in Figure 2 as the Flavanol backbone. They have never been isolated in 
nature (Forkmann and Martens 2001). This is possibly because of their tendency to 
polymerize even under the slightest perturbation in conditions or because of the highly 
efficient exchange between adjacent enzymes in the speculated flavonoid enzyme 
complex. 
It has also been suggested that leucoanthocyanidins may convert to their previous form, 
dihydroflavonols, under storage conditions (Pang, Peel et al. 2007). Therefore, generation 
of these products requires immediate acidification or lyophilization. Additionally, 
leucoanthocyanidins are the extension units for building proanthocyanidins. 
Anthocyanidins 
Anthocyanidins (Figure 2) are the precursors to flavan-3-ol units, and are also the 
unglycosylated version of anthocyanins, their more prevalent and stable counterpart. 
Anthocyanidins possess a pH dependant color that varies from orange-red to blue. 
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Anthocyanidins exist as a flavylium cation, but very little of them are found in nature. 
They exist mainly as salts or anthocyanins, and what little are found are considered 
degradation products of anthocyanins (He, Mu et al. 2010). 
Anthocyanidin is a substrate for two enzymes, marking the committed step in the 
downstream flavonoid pathway. Anthocyanidin reductase (ANR) will reduce 
anthocyanidin to a flavan-3-ol, which may condense to form proanthocyanidins. 
UDPglucose:flavonoid glucosyltransferase (UGFT) catalyze a glycosylation reaction to 
form anthocyanin. 
Anthocyanins are best known for their pigmentation seen in plants. These compounds 
also aid in the recruitment of pollinators and protect plants against UV light (Harborne 
and Williams 2000).  Furthermore, (Desai, Olsen et al. 2010) have shown that 
administering anthocyanin-rich blackberry extracts to rats will halt tumor growth and 
may even shrink tumor size. 
Flavan-3-ols 
Nine different variations on flavan-3-ols have been discovered. The basic structure is 
shown in Figure 2 as a Flavanol. The variations these variations depend on the placement 
of hydroxyl groups on the rings. In some plant species, these different molecules can be 
substituted for each other as a substrate; however, there are discrepancies in kinetic rates 
respective to the substrate and the plant species. 
Flavan-3-ols are the most commonly consumed flavonoid in our diet (Scalbert and 
Williamson 2000). They are present my many foods such as tea, fruit, legumes, 
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vegetables, and cocoa. Foods rich in flavan-3-ols (monomeric or condensed) have been 
called “superfoods” and are highly encouraged in the diet for their anti-oxidant 
properties. Since then, a broader range of foods have been examined to determine 
flavonoid quantities. In one study, 56 foods were analyzed (de Pascual-Teresa, Santos-
Buelga et al. 2000). Overall, (-)-epicatechin was shown to be the most abundant flavanol.  
Extracts from plants rich in flavonoids have shown to have cancer-preventative and anti-
cancerous properties (Ahmad, Cheng et al. 2000; Grotewold, Lin et al. 2006). These 
compounds have been shown to induce apoptosis in cancer cells (Cos, De Bruyne et al. 
2004) thereby reducing tumor formation while also reducing oxidative stress (Bagchi, 
Bagchi et al. 2000). 
These monomers are also capable of chelating transition metals, such as iron or lead, 
leading to an increased resistance to external concentrations. The presence of flavan-3-ol 
monomers (-)-epicatechin and (-)-catechin have been shown to slow or extinguish any 
invasive neighboring plant growth (Ahmad, Gupta et al. 2000; Bais, Vepachedu et al. 
2003). Furthermore, this tactic can also be used to defend against invasive 
microorganisms (Scalbert, 1991 or 1999). 
Flavan-3-ols have been shown to have anti-viral/microbial activity (Chung, Wong et al. 
1998) and may also be able to suppress Staphylococcus aureus resistance to antibiotics 
(Vinson, Mandarano et al. 2002). They can also reduce rate of adhesion of the same 
infection in human epithelial cells (Janecki and Kolodziej 2010). 
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Flavan-3-ol monomers may condense to form dimers, oligomers, and polymers (Marles, 
Ray et al. 2003), these polymers are often referred to as proanthocyanidins. 
Proanthocyanidins 
Flavan-3-ol condensation products, called proanthocyanidins or condensed tannins (CTs), 
are widely known due to their presence in grapes and wine. In 1973 CTs were speculated 
to cause an astringency to render the host unpalatable 
to microbes and animals due to a precipitation of 
proteins (Bate-Smith 1973). In fact, CTs react with the 
proline-rich proteins in the saliva and these reactions 
results in an astringency in taste (Kallthraka, Bakker 
et al. 2001) . 
There are three types of proanthocyanidins. A-type 
proanthocyanidins carry two bonds between flavan-3-
ol units. These are more structurally rigid than B-type 
proanthocyanidins. Examples of both types are shown 
in Figure 3. These dimers have one linkage that is 
either C4-C8 or C4-C6. The C-type contains at least 
three units: one initiating and two or more extension 
units (Hemingway, Karchesy et al. 1989). 
Tannins have been shown to have anti-microbial and 
anti-fungal effects in plants (Beecher 2004), among 
Figure 3. Both A-type and B-type     
(-)-epicatechin dimers 
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other protective abilities, but they also provide positive benefits for both animals and 
humans. Tannins can decrease the frequency of pasture bloat in grazing animals by 
binding reversibly to related proteins, thus slowing their degradation (L R McMahon 
2000; Dixon and Sumner 2003) . Despite their ability to form complexes with proteins 
and to exhibit anti-nutritive behavior, CTs are best known for their health benefits. These 
benefits include antioxidant action and cardio- and neuro- protective properties (Aron and 
Kennedy 2008). 
Bioavailability of proanthocyanidins has been further explored recently with studies in 
vivo and in vitro. The interactions and digestion of both proanthocyanidins and their 
monomers is not yet fully understood. A study involving human dietary intake of these 
components determined that PAs were the least absorbed class of flavonoids through the 
digestive tract (Tsang, Auger et al. 2005). Small flavanol oligomers are also thought to be 
broken down into monomeric form and are much easier to metabolize than the larger 
peptides (Scalbert, Deprez et al. 2000; Deprez, Mila et al. 2001; Manach and Donovan 
2004). It is thought that even flavan-3-ol monomers must be degraded into low 
molecular-weight metabolites before they can be absorbed by the body (Scalbert 1991; 
Rios, Gonthier et al. 2003).  
DFR 
Dihydroflavonol reductase, or DFR, is one of the last steps in flavan-3-ol biosynthesis 
and marks the beginning of a series of enzymatic reactions with highly unstable 
intermediates. It catalyzes the C-4 reduction of a dihydroflavonol to leucoanthocyanidin.  
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DFR is classified as a short-chain dehydrogenase/reductase and requires NADPH or 
NADH as a cofactor (Petit, Granier et al. 2007). It catalyzes a stereo-specific reaction to 
form a 3,4-cis diol from a dihydroflavonol (Stafford and Lester 1985). A crystal structure 
has only been obtained in grape (Petit, Granier et al. 2007). Excluding the C-terminal, 
both amino acid sequences are highly similar (77% identity). The crystal structure 
showed that the substrate is wrapped up by both the N- and C-terminals of the enzyme 
and that the NADPH binding site is located mainly in the N-terminal, which forms a 
characteristic Rossmann fold (Petit, Granier et al. 2007). 
AtDFR has previously been recombinantly expressed in E. coli, also in other species, 
some of which have been characterized (Yan, Chemler et al. 2005; Leonard, Yan et al. 
2008; Singh, Kumar et al. 2009). 
ANS 
Anthocyanidin synthase (ANS) follows DFR 
in the flavonoid pathway. It corresponds to 
the TDS4 gene in Arabidopsis and is also 
referred to as LDOX, for leucoanthocyanidin 
dioxygenase (Abrahams, Lee et al. 2003). 
ANS is classified as a 2-oxoglutarate 
dependant, non-haem dioxygenase, and 
therefore requires 2-oxoglutarate and Fe(II) 
as cofactors. ANS also requires the presence 
Figure 4. Crystal structure of ANS from A. 
thaliana, complexed with narigenin 
(Turnbull, Prescott et al. 2001) 
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of oxygen and an unusually high concentration of ascorbate for activity (Saito, Kobayashi 
et al. 1999).  
ANS from A. thaliana has been purified and crystallized, the structure can be seen in 
Figure 4 (Turnbull, Prescott et al. 2001).   This enzyme catalyzes the next step towards 
flavan-3-ol biosynthesis: oxidizing flavan-3,4-diols to anthocyanidins. Here, both the 
substrate and product are relatively unstable. There have been different studies about the 
stereospecificity of this enzyme and the nature of its products. Leucoanthocyanidin 
stereochemistry has been shown in vitro to affect product outcome. This can be seen in 
Figure 5.  It has been speculated that the 3,4-diol will become either an anthocyanidin or 
a dihydroflavonol after the first catalytic cycle from ANS. It is further speculated that the 
dihydroflavonol will further oxidize to a flavonol after a second catalytic cycle (Turnbull, 
Nagle et al. 2003).  
Figure 5. Different reactions catalyzed by ANS. Note that substrate stereochemistry may 
vary product ratios 
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Further characterization of this enzyme (Turnbull, Nakajima et al. 2004) experimented 
with the product outcomes of different substrate stereochemistry. In the direct flavan-3-ol 
pathway, ANS was found to react with the leucoanthocyanidin to form a cyanidin 
(Turnbull, Sobey et al. 2000).  Complication due to the instability of substrates and 
products, further levels of oxidation, and the compounds forming complexes with the 
Fe(II) results in indirect evidence for the true mechanism and product(s). From the 
natural 2,3 cis- form of leucocyanidin, cyanidin was the least prevalent of the products 
from ANS, accounting for only 2%, while quercetin took 85% of the product profile 
(Turnbull, Sobey et al. 2000).  
ANR 
The last step, from anthocyanidin to 
flavan-3-ol, is catalyzed by another 
NADPH- dependent enzyme, 
anthocyanidin reductase (ANR). ANR 
resides in the BANYULS gene, which, 
when mutated, allowed accumulation 
of red anthocyanin pigments and loss 
of proanthocyanidins (Xie, Sharma et 
al. 2003). Since there were many 
similarities in sequence to DFR, the BAN gene was originally thought to encode an 
enzyme called leucoanthocyanidin reductase, or LAR, to form the flavan-3-ol (+)-
catechin (Devic, Guilleminot et al. 1999). Later, BAN from A. thaliana was shown to 
Figure 6. Flavan-3-ol monomers. Substrates are 
italicized, enzymes are denoted in bold.  
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catalyze the formation of (-)-epicatechin from cyanidin, leading to the discovery of ANR 
(Xie, Sharma et al. 2003). Both flavan-3-ol monomers are shown in Figure 6. 
Along with the discovery of ANR came the discovery of the stereochemistry of PAs in A. 
thaliana. The lack of (+)-catechin suggested the dominance of ANR activity and 
eventually led to the lack of a gene encoding LAR (Abrahams, Lee et al. 2003). 
Additionally, a full characterization of AtANR recombinantly expressed in E. coli has 
been performed alongside the ANR form Medicago trucatula (Xie, Sharma et al. 2004). 
Enzyme Attachment 
In the prospect of creating processes that are more commercially and industrially 
efficient, techniques have been developed for application in biochemistry. Enzyme 
attachment to a platform has been shown to provide many benefits for long-term or 
recovered processes (Sheldon 2007). By using immobilization techniques, biocatalysts 
can be used in continuous cascade reactions (Veum and Hanefeld 2006). This can also be 
used to aide stability of a biocatalyst (Cabral and Kennedy 1993), which may increase 
enzyme performance and percent recovery of the biocatalyst. Immobilization may also 
allow the enzyme to withstand more extreme temperatures or pH. 
Concerning the biosynthesis of flavan-3-ols, there has been little related research. 
(Deffieux, Gaudrel-Grosay et al. 2009) has used attachment by immobilizing and further 
stabilizing leucoanthocyanidins instead of attaching the enzyme catalyzing the reaction.  
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(El-Zahab, Jia et al. 2004) used lactose dehydrogenase, glucose dehydrogenase, and the 
cofactor, NADH, all tethered to silica glass platforms. Variations in chain length showed 
differences in the use and generation of NADH between the two enzymes. This 
experiment was duplicated replacing glucose dehydrogenase with glutamate 
dehydrogenase (Liu, Zhang et al. 2009). Both showed very high regeneration and 
turnover of the cofactor. 
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Hypothesis 
Our objective is to combine the concepts of the flavonoid multi-enzyme complex and 
biocatalyst immobilization to create a more efficient, synthetic flavan-3-ol biosynthesis 
complex. This complex will include the enzymes from the late steps in the flavonoid 
pathway leading to the biosynthesis of flavan-3-ols, molecules that have many beneficial 
attributes, especially in human health.  
This will be achieved by creating site-specific attachments on a nanocarrier. The enzymes 
will be bound by their fusion tags to their respective sites and thus co-localizing around 
each other, creating a small environment in which to transport unstable intermediates and 
increase outflux of the desired product.  
We propose that immobilization of the enzymes in the late flavonoid pathway to a 
nanocarrier platform will be beneficial to this scheme in multiple ways. First, it will 
provide the enzymes with a support and stability that they would not be able to attain in 
solution. As stated earlier, immobilization can also allow the enzyme to withstand more 
extreme conditions and resist denaturation. Second, with the immobilized enzymes co-
localized onto the same nanocarrier, shuttling of the intermediates will thereby diminish 
transport losses and prevent unwanted side products. 
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Chapter 2: Purification of Arabidopsis DFR, ANS, and ANR for site-
specific attachment onto a chemically modified nanocarrier 
 
Abstract 
Flavonoids and their derivatives are a group of highly researched secondary metabolites. 
They are well known for their beneficial and protective qualities in plants as well as in 
humans. Products of this pathway are highly revered as being supplemental to human 
health. Like many plant pathways, the close interactions and intricate design gives a 
strong argument for the existence of a multi-enzyme complex. Here, the enzymes 
involved in the late steps in the flavonoid pathway leading to flavan-3-ol, or epicatechin, 
biosynthesis are purified for co-localization onto a polymer. To do this DFR, ANS, and 
ANR from A. thaliana were recombinantly expressed in E. coli, purified for using 
specific affinities, and assayed for activity. In the future, they will work together to create 
a more efficient flux throughout the final steps in flavan-3-ol biosynthesis. 
Introduction 
Flavonoids comprise one of the largest groups of natural products in plants. There are at 
an estimated 10,000 different compounds known today (Tahara 2007). Derived from the 
phenylpropanoid pathway, these products carry an interesting variety of secondary-
metabolic functions. They have a substantial impact on human health, showing anti-
cancer, anti-obesity, anti-oxidant, and anti-microbial properties (Chung, Wong et al. 
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1998; Cos, De Bruyne et al. 
2004; Tsuda, Ueno et al. 2006) 
. Products of this pathway also 
show defensive properties in 
plants. They protect against 
UV light, attract pollinators, 
act as a defense mechanism, 
and can even assist in fertility 
of the plant (Harborne and 
Williams 2000). Apart from 
their many health and survival 
benefits, flavonoids also have 
a variety of functions. 
Condensed tannins, a 
polymerized form of flavonoid 
monomers, have an 
astringency and can be used in 
drinks such as wine to achieve 
a specific taste (Bate-Smith 
1973). Anthocyanins, a glycosylated derivative of the same flavonoid monomer, are the 
largest group of natural water-soluble pigments. They provide the brilliant red, orange, 
and blue pigments in plants and can be used as an alternative for banned or artificial dyes 
(Yan, Chemler et al. 2005).  
Figure 7. Late flavonoid pathway in Arabidopsis 
thaliana. Grayed arrows are noted in vitro reactions 
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There are many outcomes to the flavonoid pathway (Figure 1). One specific path is the 
production of flavan-3-ols and their polymerized form, proanthocyanidins (PAs), 
otherwise known as condensed tannins (CTs). The branching point for this is marked by 
the reaction of dihydroflavonol reductase (DFR). The latter steps in this pathway can be 
seen in Figure 7 and contain highly unstable intermediates. Leucoanthocyanidin, the 
product of DFR, is a highly reactive compound and readily polymerizes even under the 
slightest change in conditions. This first intermediate is then used by anthocyanidin 
synthase (ANS) which catalyzes the reaction to form anthocyanidin. This flavylium 
cation is finally reduced by anthocyanidin reductase (ANR) to form the final flavan-3-ol. 
While this pathway has been under investigation for over 50 years, the last steps to 
proanthocyanidins remain unknown. 
Over the years, there has been much speculation about the nature of this pathway. 
Because of its unstable intermediates, enzyme-enzyme interactions, and high level of 
regulation, it has been proposed to exist in an arranged multi-enzyme complex (Burbulis 
and Winkel-Shirley 1999). These complexes, or metabolons, facilitate organized and 
efficient product output. They rely on some interaction with a surface, in this case the 
endoplasmic reticulum membrane, to provide stabilization and a platform on which to 
build (Hrazdina and Wagner 1985).  
These multi-enzyme complexes can be seen as a way to provide more efficient and 
interactive activity inside the cell. Developing a way to synthetically create one of these 
complexes could provide many benefits to providing more efficiency in synthetically 
creating these end products, even in large-scale processes. Enzymes are currently being 
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used as biocatalysts in industry as more and more natural products and their derivatives 
are being used as pharmaceuticals or in the health market (Paterson and Anderson 2005) . 
Enzymes can function with a higher level of substrate or stereo- specificity that is 
unattainable by traditional chemical processes. As always, there is a high demand in 
industry, especially in pharmaceutics, to create highly efficient, high output processes. 
Immobilizing enzymes as catalysts not only overcomes current setbacks in traditional 
chemical processes, but can increase stability and recovery of the biocatalyst, lowering 
production costs and increasing product yield. Harnessing protein engineering, and 
recombinant protein expression in species such as E. coli, allows for a lower cost of 
biocatalyst production (Sheldon 2007). Using these methods and applying them to these 
synthetic metabolons, would aid in the formation of compounds from pathways with 
unstable intermediates and low product yields in vitro, such as the lower flavonoid 
pathway. 
To achieve co-localization on a platform, site-specific immobilization techniques will be 
used. Therefore, enzymes must carry the proper tags to bind to their respective sites while 
still retaining their own structure and function. Here, we develop a system on how to 
express and purify these tagged enzymes to complement the chemical modifications on 
the biopolymer platform. 
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Methods 
Materials 
Standards for TLC analysis ((-)-epicatechin, quercetin, cyanidin chloride, and 
dihydroquercetin) were purchased from Indofine Chemical Company Inc. (Hillsborough, 
NJ).  Thrombin was purchased from VWR International (Radnor, PA). All other reagents, 
substrates, and chemicals used were purchased from Sigma-Aldrich (St. Louis, MO).  
C41(DE3) chemically competent cells were purchased from Lucigen (Middleton, WI) 
and Arctic Express (DE3) cells were purchased from VWR Scientific for protein 
expression. Top10 competent cells were purchased from Invitrogen (Carlsbad, CA).  
All PCR primers were synthesized by Invitrogen. Takara Primestar HS Polymerase was 
ordered from Fischer Scientific (Waltham, MA). Accuprime Pfx polymerase was ordered 
from Invitrogen. 
DNA Manipulations 
Native AtANR was obtained from the TAIR database. AtDFR and AtANS amino acid 
sequences were taken from TAIR and synthesized into pUC57 and codon optimized for 
growth in E. coli (Genscript USA Inc.).  A (glycine3-serine1)4 linker was placed on the N-
terminus in between the amino acid sequence for AtANS and the sequence for a 
monomeric streptavidin tag.  
PCR for AtANR was done with Accuprime Pfx polymerase (Invitrogen) using an initial 
melting temperature of 95˚C for 5 minutes, then 34 cycles of  30 sec at 94˚C, 30 seconds 
at 62˚C, and 2 minutes at 72˚C, followed by 7 minutes at 72˚C and 10 minutes at 4˚C. 
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AtDFR and AtANS were cloned using Takara Primestar HS polymerase. Both genes 
were cloned using the Primestar 2-step method with an elongation time of 1.75 minutes 
for AtDFR and 2.5 minutes for AtANS. Primers used to isolate these genes were ordered 
from Invitrogen and diluted to 5 nmol concentrations. They can be seen in Table 1. 
Table 1. List of primers used for cloning PCR , all from 5‟ to 3‟  
 Forward Reverse 
AtANR 
CACCATGGACCAGACTCTTACACACACCGGA
TCG CACCTCATTTAGCTTTGATCAATCCTTTTGACTC 
AtDFR CACCATGGTGTCCCAAAAAGAAACGGTG TCAAGCACACATCTGTTGCGCCAGCATC 
AtANS 
GGGACAAGTTTGTACAAAAAAGCAGGCTTCG
AAGGAGATAGAACCATGGACCCGAGCAAAG
ACAG 
GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAAT
CATTTTTTTCAGACA 
 
Proper isolation of the correct gene was determined using electrophoresis in a 1.5% 
agarose gel. After confirmation by size, the correct DNA fragment was purified by a 
Millipore DNA gel purification kit and confirmed with full genetic sequencing. 
AtANR and AtDFR fragments were inserted into pENTR using the SD/D TOPO enzyme 
from Invitrogen‟s Gateway® recombination system by following protocol. AtANS was 
inserted into pDONR221 using the BP clonase enzyme from the Gateway® system 
following the manufacturer‟s protocol. Both were transformed using Top10 cells 
(Invitrogen) and propagated on NZY medium plates with 1.5% (w/w) agarose and 50 
µg/mL kanamycin. 
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All genes used were inserted into their respective destination vector (ANR: pDest17, 
DFR and ANS: pDest15) using the Gateway® LR clonase enzyme and following 
protocol. These reactions were transformed again into Top 10 cells for DNA propagation. 
Expression 
For protein expression of ANR and DFR, genes were transformed using C41 (DE3) cells 
with and without the chaperones Gro EL/ES. 5 mL cultures were inoculated with one 
colony from the transformation and were shaken at 37˚C overnight. They were enlarged 
at 37˚C to 50 mL of NZY media for 2 hours, and then transferred to 1 L NZY at 200 rpm. 
Cultures were grown until the media reached 0.6-0.8 Abs600. The cells were immediately 
moved to shake at 16˚C for 1 hour. After equilibration at 16˚C they were induced by 1 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and left to shake overnight. 
ANS was expressed with both C41 (DE3) chemically competent cells and the Arctic 
Express RP cell line. After transformation, 5 mL cultures of both cells were grown 
overnight at 37˚C from one colony. Cultures were enlarged to 50 mL of NZY media for 2 
hours, and then transferred to 1 L of NZY. C41 cells were shaken at 200 rpm at 37˚C 
until media reached 0.6-0.8 Abs600. All cultures containing 50 µg/mL carbenicillin. Cells 
were allowed to equilibrate at 16˚C for 1 hour and induced by 1 mM IPTG for a total 
induction time of 14 hours. Arctic Express cells were grown in 5 mL NZY overnight at 
37˚C with 50 ug/mL carbenicillin. These were enlarged to 50 mL of NZY media with no 
antibiotic for 2 hours, shaking at 220 rpm at 30˚C and then enlarged to 1 L NZY with no 
antibiotic. This was allowed to shake for 3 hours at 30˚C, then moved to shake at 11˚C 
for 1 hour before induced with 1 mM IPTG and shaken for 24 hours. 
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Cells were harvested by centrifuging media at 6,000 g for 20 minutes.  The supernatant 
was poured off and the cell pellet resuspended in lysis buffer (50 mM Bis-Tris, pH 6.8, 
150 mM KCl, 10 mM MgCl2, 10% Glycerol). The resuspended cells were lysed by 
sonication (Branson Sonifier 450: 3 × 8 s continuous output, at a setting of 4). The lysate 
was clarified by centrifugation at 16,000 g for 20 minutes. 
Purification of AtANR 
ANR/pDest17 (38,745 kDa) lysate was incubated on a rotisserie at 4˚C for 2 hours with 
2mL Nickel-NTA resin (50% v/v in equilibration buffer: 50 mM Bis-Tris, pH 6.8, 1 mM 
DTT). The mixture was poured into a mini column under gravity flow. The beads were 
washed with four volumes of binding buffer I (50 mM Bis-Tris, pH 6.8, 10 mM 
imidazole, 1 mM DTT) then washed with a third volume of binding buffer II (50 mM 
Bis-Tris, pH 6.8, 20 mM imidazole, 1 mM DTT). The protein was eluted with 5 mL of 
elution buffer (50 mM Bis-Tris, pH 6.8, 250 mM imidazole, 1 mM DTT).  
The imidazole was removed from the eluate by concentration through a Peirce 20 kDa 
MWCO protein concentrator to about 1 mL. The resulting protein was diluted 1:10 in dI 
water with 1 mM DTT and loaded onto a Mono Q HR 5/5 (GE Healthcare) column 
connected to an AKTA FPLC system. The column used buffer A as 50 mM Bis-Tris 
buffer and buffer B as 50 mM Bis-Tris and 3 M NaCl, both pH 6.8. The method is as 
follows: 0-4 minutes at 2% buffer B, 4-14 minutes gradient to 10% buffer B, 14-17 
minutes at 100% buffer B. Flow rate was 1 mL/ min with 0.5 mL fractions collected, all 
at 4˚C.  
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Selected fractions were collected and analyzed by SDS-PAGE and quantified by A280 
with an extinction coefficient of 31,750 M
-1 
cm 
-1
.  
Purification of AtDFR 
1 mM Triton®X-100 was added to the clarified lysate containing AtDFR/pDest15 
(70,155 kDa) and was incubated at 4˚C for 1 hour on a rotisserie with 2 mL glutathione-
agarose resin (50% v/v in sterile dI water). Lyophilized resin had been allowed to swell 
by gentle mixing on a rotisserie for 24 hours in 13 mL sterile dI water at 4˚C. 1 mM 
DTT, 0.1 mM EDTA, and 0.1 mM phenylmethylsulfonyl fluoride (PMSF) were added 
during incubation and to each following wash step. 
After incubation, resin was collected by spinning at 1,000 rpms in a clinical centrifuge at 
4˚C. Supernatant was discarded and two volumes of equilibration buffer (10 mM 
phosphate, pH 7.4, 150 mM NaCl, 1% Triton®X-100) were added. This was mixed on a 
rotisserie at 4˚C for 1 minute. The resin was collected as described previously. This was 
repeated 3 times.  
Two elutions were performed, totaling 5 volumes of elution buffer (10 mM phosphate, 
pH 7.4, 150 mM NaCl, 1% Triton®X-100, 10 mM glutathione). Each elution was mixed 
at 4˚C for 5 minutes. 1 mM DTT was added to final volume. 
Eluate was analyzed by SDS-PAGE and quantified by A280 using an extinction coefficient 
for both DFR and the GST tag (85,930 M
-1 
cm 
-1
). 
Purification of AtANS 
AtANS/pDest15 (85,282 kDa) followed the same affinity purification protocol as AtDFR. 
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Fractions were analyzed with SDS-PAGE, those containing ANS were quantified by A280 
using the molar extinction coefficient 126 110 M
-1 
cm 
-1
 with fusion to GST and 84 950 
M
-1 
cm 
-1
 with no GST fusion tag. 
Activity Assays 
For initial AtANR assays, optimal conditions, from a previous characterization (Xie, 
Sharma et al. 2004), were given to ensure enzymatic activity. 100 µg of enzyme (or 100 
µL of lysate, for lysate kinetics) was added to each assay. The ANR assay had a total 
volume of 1 mL and consisted of 100 mM Tris-HCl, pH 8.0, 2 mM NADPH, 50 mM 
NaCl, 10% glycerol, and 100 µM cyanidin chloride. Kinetics were performed at 55˚C. 
Each was stopped by the addition of 1 mL of ethyl acetate and 1 minute of vortexing. The 
top layer was extracted and emulsions were broken by centrifugation at 3,000 rpm in a 
clinical centrifuge. The extraction was repeated two times for a total volume of 3 mL of 
ethyl acetate. Extracts were dried under nitrogen gas. For lysate kinetics they were re-
dissolved in 1 mL methanol for UV analysis. For the purified protein the assays were re-
dissolved in 25 µL of methanol for TLC analysis. Cellulose TLC plates using a 1:3 
methanol:methylene chloride solution were used as described in (Dobashi, Hirano et al. 
2008) 
AtDFR assays consisted of 100 mM Tris-HCl, pH 7.0, 50 mM NaCl, 2 mM NADPH, and 
100 µM dihydroquercetin (DHQ) in 1 mL. 100 µL of lysate was added and the reaction 
was incubated at 30˚C. Extractions followed the same protocol as the ANR assay 
extraction. After drying with nitrogen gas the residual was dissolved in a n-butanol/HCl 
(95%/5% v/v) solution and incubated at 95˚C for 30 minutes as described (Stafford and 
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Lester 1980). This process converts the unstable leucocyanidin to cyanidin (perhaps only 
at 40% efficiency (Stafford and Lester 1982)) and can be subject to UV analysis at 550 
nm. 
ANS assays contained 100 mM Tris-HCl, pH 7.0, 40 mM ascorbate, 5 mM Fe(II) sulfate, 
5 mM 2-oxoglutarate, and 100 µM DHQ in 1 mL and used the same extraction 
procedure. This assay was to measure turnover from DHQ to quercetin. Because both 
substrate and product were colorless, qualitative analysis was performed on TLC with the 
same method as ANR. 
Once activity was confirmed in the lysates, a collective assay buffer was used. The 
general assay buffer contained 100 mM Tri-HCl, pH 7.0, 40 mM ascorbate, 5 mM Fe(II), 
5 mM 2-oxoglutarate, and 1 mM NADPH. These assays were performed in a 37˚C water 
bath. Table 2 shows the conditions for enzyme and substrate concentrations for each 
enzyme‟s respective assay. Total volume of each assay was 500 µL. 
Table 2. Specifications for each enzyme and its respective substrate in the co llective assay 
buffer 
 ANR ANS DFR 
Enzyme 150 µg 100 µg 50 µg 
Substrate 100 µM 800 µM 500 µM 
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Thrombin Cleavage 
Two different concentrations of thrombin were used to run the cleavage reaction. The 
first reaction was run at 4˚C at a concentration of 0.5 NIH units/nmol enzyme. The 
second reaction was carried out at both room temperature and 4˚C. This reaction was run 
at a concentration of 25.7 NIH units/nmol enzyme. Thrombin was reconstituted in 50 
mM Tris-HCl, pH 7.0. The final reaction volume contained 150 mM NaCl and 2.5mM 
CaCl2. Reactions were placed on a rotisserie for gentle mixing. Time points were taken 
during the reactions and analyzed by SDS-PAGE. 
Results  
The glycerol stock of the wild type A. thaliana ANR had been previously attained from 
the TAIR database and was a prime model for recombinant expression in this study. ANS 
needed a tag and linker and was planned to be synthesized at Genscript. DFR was also 
planned to be expressed because of the greater stability of its substrate, even though it has 
been shown to have low activity in E. coli (Martens, Teeri et al. 2002). DFR was also 
synthesized at Genscript. Both synthetic genes were codon optimized for expression in E. 
coli. 
All genes were cloned using primers to make them accessible to the Gateway® system. 
ANR and DFR were readily cloned into the pENTR vector by the TOPO cloning enzyme. 
ANS, however, did not go into pENTR and instead used pDONR221 as an entry vector 
with BP clonase. Although only 51% GC content in nucleic acid makeup, ANS would 
only be amplified out of its original vector by Takara PrimeStar, a polymerase used 
especially in GC-rich genes. 
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Expression studies were done with multiple cells 
lines and chaperones. Each enzyme was 
overexpressed in three systems: 1) C41 (DE3), 2) 
C41 (DE3) – co-transformed with Gro EL/ES, and 
3) Arctic Express (DE3) RP competent cells. Gro 
EL/ES didn‟t assist overexpression in C41, 
therefore for both ANR and DFR the single 
transformation C41 cells were used. ANS was 
expressed and purified in both C41 and Arctic 
Express for comparison in the amount of in-tact DM3 tag 
on the protein. 
AtDFR was expressed using the pDest15 vector which 
contains an N-terminal GST-tag, cleavable by thrombin 
and also in pDest14, a vector for expression of an untagged 
enzyme. Lysate kinetics with DFR in both pDest15 and 
pDest14 showed that both constructs were active. Also, the 
pDest15 construct retained activity after purification with 
glutathione resin.  
Further purification produced about 90% purity as seen in 
Figure 10. Activity was tested by acid hydrolysis of the 
assay extracts producing a pink color corresponding to the 
Figure 9. Left - DFR assay 
extracts after acid hydrolysis to 
convert leucocyanidin to 
cyanidin (pink). Right – control 
(clear) 
Figure 8. PCR product of ANS. Lane 
1) 500 bp ladder, lane 2) PCR 
product to be purified from 
ANS/pDONR, lane 3) positive ANS 
control from original pUC57 vector  
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formation of cyanidin from leucocyanidin. An example of these results can be seen in 
Figure 9.  
 
Figure 10. Purification of DFR/pDest15 - (starting from left) lane 1) lysate, lanes 2-4) resin 
washes, lane 5) eluate, lane 6) empty, lane 7) standard ladder  
 
Figure 11. Lysate kinetics for AtDFR as an untagged enzyme (pDest14) and with a GST tag 
(pDest15). Absorbance at 550 nm corresponds to the amount of cyanidin resulting from the acid 
hydrolysis of leucocyanidin produced by the enzyme  
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The 6xHis-Ni purification system is a widely used purification method and the 6xHis 
fusion tag exists in the Gateway® system as pDest17. The Gateway® cloning and 
expression system was used to achieve an N-terminal 6xHis tag on ANR. Recombinantly 
expressed AtANR in E. coli has previously been characterized (Xie, Sharma et al. 2004). 
ANR was twice purified, once with Ni-NTA resin and then again with anion exchange 
FPLC.  Figure 12 shows a purified ANR peak at fractions A2-A4.  
 
  Figure 12. FPLC chromatogram of purifying AtANR; purified protein peak between 3.5-4 mL 
Activity of AtANR lysate was tested by using UV analysis. Its substrate, cyanidin, has a 
red color and has a maximum absorbance at 550 nm. Assay extracts were expected to 
shift in absorption from 550 nm to 280 nm, the maximum absorbance of epicatechin. 
Using a negative controlled assay, the absorbance at 280 nm was monitored over time, 
representing the production of epicatechin from cyanidin, the results of which can be seen 
in Figure 13. 
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Figure 13. Averaged ANR assay results showing increasing absorbance at 280 nm, the 
maximum absorbance wavelength for epicatechin. Data was taken from two different 
purification batches 
To qualitatively show ANR activity, extracts were dried down and re-dissolved in 25 µL 
of methanol. 2.5 µL was used on a silica TLC plate against the product standard, shown 
in Figure 14. 
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Figure 14. TLC with ANR assay extractions. Lane 1) ANR 
with no substrate, lane 2) ANR with cyanidin substrate, 
lane 3) epicatechin standard, lane 4) DHQ standard, lane 5) 
quercetin standard. Rf values for epicatechin in assay 
(0.643) and standard (0.610) 
33 
 
For the attachment of ANS to the biotin on the polymer platform, an avidin or 
streptavidin tag was needed. A single-stranded streptavidin double-mutant was developed 
by (Qureshi and Wong 2002) titled DM3. This mutant contained two single-point 
mutations in the monomeric version of streptavidin that allowed the single strand to exist 
solely as a monomer even at room temperatures. It also gave the mutant a higher binding 
constant for biotin than the other double mutants (1.28 x 10
-8
 M), though not as high as 
the tetrameric form of streptavidin (≈ 10-14 M).  
Because of the need to perform an affinity purification with ANS, the gene was inserted 
into pDest15 which contains an N-terminal GST tag. This also helped to distinguish 
between the enzyme (58.4 kDa) and the Cpn 60 chaperone present in the Arctic Express 
cells (60 kDa).  
TLC was used to find ANS activity, shown by oxidizing DHQ to quercetin. A 1 hour 
assay extract was dried under nitrogen gas and re-dissolved in 25 µL of methanol. 5 µL 
were run next to DHQ and quercetin standards, shown in Figure 15.  
 
 
 
Figure 15. TLC of ANS assay extracts. Arrow is 
pointing to product (quercetin) band. Lane 1) ANS 
assay, lane 2) epicatechin  standard, lane 3) DHQ 
standard, lane 4) quercetin standard. Rf values: for both 
quercetin generated in assay and the quercetin standard 
at 0.926 
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To remove the GST tag before attachment to the polymer, a thrombin cleavage was 
performed. The cleavage site was predicted by PeptideCutter (SIB Swiss Institute of 
Bioinformatics (Gasteiger E., Gattiker A. et al. 2003)). The predicted cleavage site leaves 
13 amino acids to the N-terminal of the sequence as displayed in Figure 6. The amino 
acids were not predicted to affect binding to biotin. 
 
Figure 16. Shows the predicted thrombin cleavage site between the GST tag and the ANS 
enzyme with glycine-serine linker and N-terminal DM3. The added 13 amino acids after 
cleavage are bolded and underlined 
Discussion 
Many studies have been done to elucidate the flavonoid pathway and to characterize the 
enzymes and phenotypic mutants. Products from this pathway are gaining notoriety as a 
group of highly functional compounds. To obtain these products, unstable intermediates 
are sequestered through a highly regulated series of enzymes. Co-localization and cell 
fractionation experiments show that many enzymes occupy the same physical area within 
the cell (Hrazdina and Wagner 1985; Saslowsky and Winkel-Shirley 2001; Saslowsky, 
Warek et al. 2005). Also, metabolic research has shown high levels of regulation 
throughout most of the pathway (Burbulis and Winkel-Shirley 1999; Abrahams, Lee et al. 
2003). This evidence indicates that a multi-enzyme complex is likely for the flavonoid 
pathway enzymes. Products of the flavonoid pathway are involved in plant survival, 
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defense, and proliferation and have proven useful in human health and disease prevention 
(Cos, De Bruyne et al. 2004; Aron and Kennedy 2008). Their wide scope of applications 
has made the flavonoid pathway a target of many research teams. Here, protein 
expression and purification has been performed in pursuit of creating a site-specific 
method of attachment for these enzymes in multi-enzyme complexes.  
With recombinant expression in E. coli, we have produced three functional flavonoid 
enzymes from the model plant Arabidopsis thaliana: dihydroflavonol 4-reductase, 
anthocyanidin synthase, and anthocyanidin reductase. These enzymes catalyze the final 
steps in the flavonoid pathway and produce epicatechin, a flavan-3-ol monomer. These 
compounds have a variety of health benefits and applications as well as being the 
building blocks for proanthocyanidins, a class of condensed flavonoids with similar 
functions (Chung, Wong et al. 1998; Cos, De Bruyne et al. 2004).  
ANR has previously been characterized in A. thaliana (Xie, Sharma et al. 2004) and ANS 
has been purified and crystallized (Turnbull, Prescott et al. 2001). Until recent years, 
recombinant expression of DFR in E. coli has been unsuccessful in yielding soluble and 
functional enzymes in vitro (Leonard, Yan et al. 2008). Now, under different expression 
and purification systems, a unique form of each enzyme has been expressed, purified, and 
recovered retaining enzyme activity. 
The goal for choosing an expression and purification system was to obtain a unique tag 
for ANS and ANR so that each could be attached to a chemically modified polymer 
surface. These attachments are separate and unrelated in that the location and spatial 
density of each enzyme could be manipulated by the attachment modification procedure. 
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The two chemical surface modifications that were chosen were nickel and biotin. 
Therefore, the enzyme tags would become 6xHis and streptavidin, respectively, due to 
their high binding affinity. 
A covalent attachment of the enzyme to the polymer could be performed, but because of 
lack of specificity of a binding site on the protein this could cause deactivation of the 
enzyme as well as blockage to the active site. This could render a portion of the attached 
enzyme denatured or without activity. Thus, a tag or fusion protein tag would be more 
beneficial to predict binding patterns. 
Although DFR would not be attached to the polymer platform initially, affinity 
purification would allow for better control and purity of the leucocyanidin products after 
assay extraction. With the N-terminal GST tag near the location of the NADPH binding 
site (Rossmann fold), activity might have been hindered by blocking or reducing 
accessibility of this site. DFR was expressed in both the pDest14 (untagged) and pDest15 
(N-terminal GST tag) expression vectors. Activity was shown in both systems and did not 
decrease when expressed as a fusion protein to GST, suggesting that the N-terminal tag 
did not adversely affect the ability of the enzyme to utilize NADPH. Although GST is 
used a transporter for some flavonoid compounds, for example anthocyanins, using a 
GST tag hasn‟t shown any binding or inhibition with DFR substrates or products 
(Hayashi, Takahashi et al. 2005). 
Using a GST tag to purify DFR would allow for two options concerning leucocyanidin. 
For production and storage of the leucocyanidin substrate, the DFR-GST fusion protein 
could be purified and used to create leucocyanidin which could then be lyophilized and 
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stored at -80˚C for use in future assays. Although, leucocyanidin has been shown to 
convert to DHQ under storage (Pang, Peel et al. 2007). Otherwise, the DFR-GST fusion 
protein could remain bound to the glutathione resin. After washing the resin thoroughly, 
DFR could be introduced to the assay, incubated for leucocyanidin production, and then 
removed with the resin by centrifugation. Because DHQ is both a substrate from DFR 
and a product of ANS, this would eliminate circulation of DHQ throughout the system. 
Cleavage of the tag may not be necessary. 
Expression of ANS in pDest14 produced very little expression in C41 cells. Arctic 
Express cells or C41 cells co-transformed with a Gro EL/ES chaperone were employed to 
facilitate expression. These cells, however, express a folding chaperone approximately 
the same size at ANS. Protease activity was also hypothesized due to a large 
overexpression band at approximately 40 kDa, possibly corresponding to the size of ANS 
without the DM3 (monomeric streptavidin) tag. To create an affinity purification 
procedure for ANS, it was expressed in pDest15, which altered the size of the protein to 
84 kDa. This allowed for a differentiation between ANS and the 60 kDa folding 
chaperone. This expression and purification was performed in both Arctic Express and 
C41 yielding comparable amounts of protein. Both retained activity as a double fusion 
protein with DM3 and GST on the N-terminal. Purity of ANS after GST elution was 
reduced due to poor recovery of the resin during batch purification.  
The DM3 tag was chosen for simplicity in design and its ability to bind biotin with a 
sufficiently low dissociation constant. Although the affinity is not as high as the wild-
type streptavidin (Kd ≈ 10
-14 
M), it still maintains a dissociation constant of 1.28 x 10
-8 
M, 
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which is higher than that of a monomeric avidin (Kd = 1.8 x 10
-7 
M) used for commercial 
affinity purposes. This DM3 sequence is a double-point mutation of the single stranded 
streptavidin (T90A and D128A). It has proven to exist solely as a monomer (Qureshi and 
Wong 2002) and therefore it is unlikely to cause tetrameric forms of DM3-ANS. This 
sequence was synthesized at the N-terminal of the ANS gene, linked by a flexible (Gly3-
Ser)4 linker. This was to allow for proper folding of both proteins. Correct folding was 
confirmed by GST affinity to glutathione during purification and confirming ANS 
activity. The N-terminal attachment to ANS was chosen due to the fact that there were no 
residues near the N-terminal that were involved in substrate or cofactor binding 
(Wilmouth, Turnbull et al. 2002). 
Thrombin cleavage of the GST tag from the remaining DM3-ANS protein was predicted 
to only have one cleavage site, ultimately adding 13 amino acids to the final N-terminal. 
The cleavage reaction was carried out at two different concentrations at both room 
temperature and 4˚C. Running time points for the reaction up to 24 hours on SDS-PAGE 
showed that the reaction was not near completion at 4˚C, and also that there may have 
been a second cleavage site. The second site was speculated to reside near the C-terminal, 
due to similarities in the sequence to that of the cleavage point. This would cause ANS to 
lose the last 24 amino acids, some of which are involved in substrate binding. A small 
sample of the post-cleavage enzyme was run on the FPLC using anion exchange. Two 
possible bands were present and co-eluted. Furthermore, running a multi-day cleavage 
reaction at 4˚C could significantly reduce enzyme activity. Thus, the decision was made 
to attempt streptavidin affinity to biotin without cleaving the GST tag.  
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Chapter 3: General Conclusions 
In this work, we have demonstrated recombinant expression and purification of three 
enzymes in the late flavonoid pathway with the required tag specificities. Maintaining 
activity of these sequential flavonoid enzymes and their fusion tags through purification 
was the first step in building a flavonoid biosynthetic multi-enzyme complex. This will 
allow site-specific binding and spatial control of the enzymes when bound to a 
chemically modified surface. Steps have been taken to ensure that the fusion tags for 
affinity purification do not interfere with the activity of the enzyme. Additionally, the use 
of a monomeric streptavidin tag provides a simple design method for the attachment of 
enzymes onto biotinylated surfaces. These methodologies could allow for scale up 
biocatalyst processes and could be applied to any enzymatic coupling reaction. This 
provides an alternative to free enzyme reactions, where product generation may be low 
and the intermediates are unstable. By facilitating to the enzyme and reaction 
specificities, this method will allow for better regulation and control over these 
biocatalyst processes. 
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